Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Hypercholesterolemia Drugs Market (2017-2025): Forecast to Grow at a CAGR of 5.6% - Research and Markets

Research and Markets
Posted on: 21 Dec 17

The "Global Hypercholesterolemia Drugs Market, 2017 to 2025" report has been added to Research and Markets' offering.

The global hypercholesterolemia drugs market is set to grow at a CAGR of 5.6% from 2017 to 2025.

Hypercholesterolemia also known as high cholesterol, is the presence of excess levels of cholesterol in the body that increases a risk of developing heart attack, and stroke. Changes in lifestyle pattern such as the adoption of a sedentary form, increasing rate alcohol consumption and change in dietary pattern are driving the growth of hypercholesterolemia drugs market. For the purpose of the study hypercholesterolemia drugs market is segmented on the basis of drug class such as HMG-CoA reductase inhibitors/ statins, bile acid sequestrants, fibrates, cholesterol absorption inhibitors, others drugs. It is studied that, currently HMG-CoA reductase inhibitors/ statins held largest market share because statins are commonly prescribed drug class due to their safety and effectiveness in lowering cholesterol.

In the base year 2016, North America dominated the global hypercholesterolemia drugs market due to the large number of target population, rise in geriatric population, increase in number of obese population with increase in risk of cardiovascular disease are prime contributors in North America. On the other hand, Asia Pacific will grow significantly during forecast period due to changing lifestyle and growing healthcare awareness that would assist the growth of hypercholesterolemia drugs market.

Companies Mentioned

  • AbbVie Inc.
  • Aegerion Pharmaceuticals
  • Amgen Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Shore Therapeutics, Inc.
  • Teva Pharmaceuticals

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Hypercholesterolemia Drugs Market Analysis

Chapter 4 Global Hypercholesterolemia Drugs Market, by Drugs Class

Chapter 5 Global Hypercholesterolemia Drugs Market, By Geography

Chapter 6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/wr2sq2/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20171221005310/en/

Business Wire
www.businesswire.com

Last updated on: 21/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.